Abstract
The guideline ‘Dyspnea in the palliative phase’ was revised
in 2015. The members of the working group were
mandated by several scientific, professional and patient
organisations. On the basis of a bottleneck analysis
several scientific questions were formulated. The
questions about non-pharmacological and pharmacological
symptomatic treatment of dyspnea were analysed
evidence-based. In this paper a short summary
is given of the most important conclusions and recommendations
of the guideline.
in 2015. The members of the working group were
mandated by several scientific, professional and patient
organisations. On the basis of a bottleneck analysis
several scientific questions were formulated. The
questions about non-pharmacological and pharmacological
symptomatic treatment of dyspnea were analysed
evidence-based. In this paper a short summary
is given of the most important conclusions and recommendations
of the guideline.
| Original language | Dutch |
|---|---|
| Pages (from-to) | 53-56 |
| Number of pages | 4 |
| Journal | Nederlands Tijdschrift voor Oncologie |
| Volume | 13 |
| Issue number | 2 |
| Publication status | Published - Mar 2016 |